Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 76151 - 76175 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Sulindac	Approved Investigational	TBC1D10B	26000	upregulated	Sulindac results in increased expression of TBC1D10B mRNA	16p11.2	A20927
Sulindac	Approved Investigational	TBK1	29110	upregulated	Sulindac results in increased expression of TBK1 mRNA	12q14.2	A24351
Sulindac	Approved Investigational	TBX3	6926	upregulated	Sulindac results in increased expression of TBX3 mRNA	12q24.21	A20927
Sulindac	Approved Investigational	TM7SF3	51768	downregulated	Sulindac results in decreased expression of TM7SF3 mRNA	12p11.23	A24351
Sulindac	Approved Investigational	TMED9	54732	downregulated	Sulindac results in decreased expression of TMED9 mRNA	5q35.3	A20927
Sulindac	Approved Investigational	TMEM127	55654	upregulated	Sulindac results in increased expression of TMEM127 mRNA	2q11.2	A20927
Sulindac	Approved Investigational	TMEM39A	55254	upregulated	Sulindac results in increased expression of TMEM39A mRNA	3q13.33	A20927
Sulindac	Approved Investigational	TNS3	64759	downregulated	Sulindac results in decreased expression of TNS3 mRNA	7p12.3	A20927
Sulindac	Approved Investigational	TPRA1	131601	upregulated	Sulindac results in increased expression of TPRA1 mRNA	3q21.3	A20927
Sulindac	Approved Investigational	TRIM2	23321	upregulated	Sulindac results in increased expression of TRIM2 mRNA	4q31.3	A20927
Sulindac	Approved Investigational	TRIT1	54802	downregulated	Sulindac results in decreased expression of TRIT1 mRNA	1p34.2	A20927
Sulindac	Approved Investigational	TSNAX	7257	downregulated	Sulindac results in decreased expression of TSNAX mRNA	1q42.2	A20927
Sulindac	Approved Investigational	UGGT2	55757	upregulated	Sulindac results in increased expression of UGGT2 mRNA	13q32.1	A20927
Sulindac	Approved Investigational	UGT1A1	54658	upregulated	Sulindac results in increased expression of UGT1A1 mRNA	2q37.1	A24353
Sulindac	Approved Investigational	UNG	7374	downregulated	Sulindac results in decreased expression of UNG mRNA	12q24.11	A20927
Sulindac	Approved Investigational	WDR3	10885	upregulated	Sulindac results in increased expression of WDR3 mRNA	1p12	A20927
Sulindac	Approved Investigational	XBP1	7494	upregulated	Sulindac results in increased expression of XBP1 mRNA	22q12.1	A20927
Sulindac	Approved Investigational	ZNF165	7718	upregulated	Sulindac results in increased expression of ZNF165 mRNA	6p22.1	A24351
Sulindac	Approved Investigational	ZNF354A	6940	upregulated	Sulindac results in increased expression of ZNF354A mRNA	5q35.3	A20927
Exisulind	Investigational	ALOX15	246	upregulated	sulindac sulfone results in increased expression of ALOX15 mRNA	17p13.2	A24355 A24356
Exisulind	Investigational	CCND1	595	downregulated	sulindac sulfone results in decreased expression of CCND1 mRNA	11q13.3	A24357
Exisulind	Investigational	CDKN1A	1026	upregulated	sulindac sulfone results in increased expression of CDKN1A mRNA	6p21.2	A24358
Exisulind	Investigational	CDKN1B	1027	upregulated	sulindac sulfone results in increased expression of CDKN1B mRNA	12p13.1	A24358
Exisulind	Investigational	ESR1	2099	downregulated	sulindac sulfone results in decreased expression of ESR1 mRNA	6q25.1-q25.2	A24359
Exisulind	Investigational	HINT1	3094	upregulated	sulindac sulfone results in increased expression of HINT1 mRNA	5q23.3	A24358

Displaying entries 76151 - 76175 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability